We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$812B
AUM Growth
-$55.8B
Cap. Flow
-$18.8B
Cap. Flow %
-2.31%
Top 10 Hldgs %
32.22%
Holding
3,109
New
91
Increased
2,002
Reduced
738
Closed
70

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.81B
2
XYZ
Block Inc
XYZ
+$1.46B
3
ACN icon
Accenture
ACN
+$1.23B
4
GILD icon
Gilead Sciences
GILD
+$1.15B
5
VLO icon
Valero Energy
VLO
+$1.05B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.61B
2
META icon
Meta Platforms (Facebook)
META
+$2.06B
3
TSLA icon
Tesla
TSLA
+$1.81B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.72B
5
AMZN icon
Amazon
AMZN
+$1.59B

Sector Composition

Rank Sector Weight
1 Technology 30.44%
2 Healthcare 13.92%
3 Financials 12.3%
4 Consumer Discretionary 10.98%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
1201
Teva Pharmaceuticals
TEVA
$42.6B
$6.24M ﹤0.01%
405,692
-1,643,696
-80% -$29.4M
ENS icon
1202
EnerSys
ENS
$6.81B
$6.23M ﹤0.01%
68,065
+12,044
+21% +$1.17M
ACI icon
1203
Albertsons Companies
ACI
$5.83B
$6.15M ﹤0.01%
279,777
+33,420
+14% +$689K
ALLO icon
1204
Allogene Therapeutics
ALLO
$683M
$6.14M ﹤0.01%
4,206,004
-279,568
-6% -$527K
KOS icon
1205
Kosmos Energy
KOS
$1.51B
$6.13M ﹤0.01%
2,688,836
-3,859,941
-59% -$11.4M
GFL icon
1206
GFL Environmental
GFL
$14.7B
$6.09M ﹤0.01%
126,019
-5,081
-4% -$230K
CSTM icon
1207
Constellium
CSTM
$3.95B
$6.07M ﹤0.01%
601,425
-652,101
-52% -$6.93M
HWKN icon
1208
Hawkins
HWKN
$2.67B
$6.06M ﹤0.01%
57,187
+646
+1% +$71K
SONY icon
1209
Sony
SONY
$138B
$6.02M ﹤0.01%
+237,200
New +$5.48M
SN icon
1210
SharkNinja
SN
$26.2B
$6.01M ﹤0.01%
72,016
+535
+0.7% +$54.5K
CFR icon
1211
Cullen/Frost Bankers
CFR
$10.4B
$5.92M ﹤0.01%
47,311
+3,251
+7% +$437K
NYT icon
1212
New York Times
NYT
$10.3B
$5.91M ﹤0.01%
119,180
+7,566
+7% +$380K
NVS icon
1213
Novartis
NVS
$290B
$5.87M ﹤0.01%
52,648
-21,240
-29% -$2.26M
HLI icon
1214
Houlihan Lokey
HLI
$9.24B
$5.81M ﹤0.01%
35,974
+2,166
+6% +$372K
NE icon
1215
Noble Corp
NE
$7.04B
$5.79M ﹤0.01%
244,037
-2,176,207
-90% -$62.3M
THRY icon
1216
Thryv Holdings
THRY
$96.9M
$5.67M ﹤0.01%
442,842
+1,996
+0.5% +$33.1K
TMHC
1217
DELISTED
Taylor Morrison
TMHC
$5.66M ﹤0.01%
94,209
+8,071
+9% +$502K
RRX icon
1218
Regal Rexnord
RRX
$11.5B
$5.64M ﹤0.01%
49,552
+3,075
+7% +$427K
LAD icon
1219
Lithia Motors
LAD
$8.32B
$5.6M ﹤0.01%
19,075
+1,730
+10% +$589K
DCI icon
1220
Donaldson
DCI
$11.1B
$5.56M ﹤0.01%
82,944
+12,872
+18% +$890K
BIRK icon
1221
Birkenstock
BIRK
$7.54B
$5.55M ﹤0.01%
121,063
-5,533
-4% -$291K
TTEK icon
1222
Tetra Tech
TTEK
$9.09B
$5.55M ﹤0.01%
189,655
+14,767
+8% +$496K
CMA
1223
DELISTED
Comerica
CMA
$5.55M ﹤0.01%
93,914
+7,867
+9% +$494K
BERY
1224
DELISTED
Berry Global Group, Inc.
BERY
$5.49M ﹤0.01%
78,639
-8,046
-9% -$559K
AGNC icon
1225
AGNC Investment
AGNC
$13B
$5.48M ﹤0.01%
572,084
+86,074
+18% +$860K

Similar funds

T. Rowe Price Associates's Q1 2025 Portfolio in Review

As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
  • T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
  • T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
  • T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
  • T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
  • T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.